NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028
TABLE OF CONTENTS
1. NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON HORMONE
REPLACEMENT THERAPY MARKET
2.2. KEY INSIGHTS
1.1.1. INTRODUCTION OF NEW DRUG DELIVERY
SYSTEMS FOR HORMONE REPLACEMENT
1.1.2. MODERN SEDENTARY LIFESTYLES
1.2. PORTER’S FIVE FORCES MODEL
1.1.1. THREAT OF NEW ENTRANTS
1.1.2. THREAT OF SUBSTITUTE PRODUCTS
1.1.3. BARGAINING POWER OF BUYERS
1.1.4. BARGAINING POWER OF SUPPLIERS
1.1.5. COMPETITIVE RIVALRY
1.2. MARKET ATTRACTIVENESS INDEX
1.3. VENDOR SCORECARD
1.4. KEY STRATEGIC DEVELOPMENTS
1.1.1. ACQUISITIONS & MERGERS
1.1.2. PRODUCT LAUNCH & DEVELOPMENTS
1.1.3. CONTRACTS AND PARTNERSHIPS
1.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS,
& DIVESTITURES
1.2. MARKET DRIVERS
1.1.1. RISE IN AWARENESS PERTAINING TO
HEALTH PROBLEMS DURING MENOPAUSE
1.1.2. INCREASE IN PREVALENCE OF HORMONAL
DISORDERS
1.1.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS
1.2. MARKET RESTRAINTS
1.1.1. HIGH COST OF TREATMENT
1.1.2. ADVERSE REACTIONS ASSOCIATED WITH
HORMONE REPLACEMENT THERAPY
1.2. MARKET OPPORTUNITIES
1.1.1. AVAILABILITY OF ALTERNATIVE THERAPY
OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
1.1.2. LAUNCH OF TELEMEDICINE CLINICAL
PRACTICE SERVICES
2. NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY THERAPY TYPE
2.1. ESTROGEN HORMONE REPLACEMENT THERAPY
2.2. THYROID HORMONE REPLACEMENT THERAPY
2.3. TESTOSTERONE HORMONE REPLACEMENT
THERAPY
2.4. HUMAN GROWTH HORMONE REPLACEMENT
THERAPY
2.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY
3. NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY TYPE OF DISEASE
3.1. MENOPAUSE
3.2. MALE HYPOGONADISM
3.3. GROWTH HORMONE DEFICIENCY
3.4. HYPOTHYROIDISM
3.5. OTHER TYPE OF DISEASES
4. NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. PARENTERAL
4.3. TRANSDERMAL
4.4. OTHER ROUTES OF ADMINISTRATION
5. NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET – COUNTRY OUTLOOK
5.1. UNITED STATES
5.2. CANADA
6. COMPETITIVE LANDSCAPE
1.1. ABBOTT LABORATORIES
1.2. AMGEN
1.3. ANI PHARMACEUTICALS
1.4. BAYER AG
1.5. DR REDDY’S LABORATORIES LTD
1.6. ELI LILLY & COMPANY
1.7. GENENTECH INC
1.8. IPSEN
1.9. MERCK KGAA
1.10.
NOVARTIS AG
1.11.
NOVEN PHARMACEUTICALS INC
1.12.
NOVO NORDISK A/S
1.13.
PFIZER INC
1.14.
TEVA PHARMACEUTICAL INDUSTRIES LTD
1.15.
VIATRIS INC (MYLAN NV)
2. RESEARCH METHODOLOGY & SCOPE
2.1. RESEARCH SCOPE & DELIVERABLES
1.1.1. OBJECTIVES OF STUDY
1.1.2. SCOPE OF STUDY
1.2. SOURCES OF DATA
1.2.1. PRIMARY DATA SOURCES
1.2.2. SECONDARY DATA SOURCES
1.3. RESEARCH METHODOLOGY
1.3.1. EVALUATION OF PROPOSED MARKET
1.3.2. IDENTIFICATION OF DATA SOURCES
1.3.3. ASSESSMENT OF MARKET DETERMINANTS
1.3.4. DATA COLLECTION
1.3.5.
DATA VALIDATION & ANALYSIS
LIST OF TABLES
TABLE 1: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
& MERGERS
TABLE 4: LIST OF PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND
PARTNERSHIPS
TABLE 6: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
LIST OF FIGURES
FIGURE 1: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $
MILLION)
FIGURE 5: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: UNITED STATES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: CANADA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
MARKET OUTLOOK
As per Triton Market Research’s report, the hormone replacement therapy
market in North America is estimated to garner a CAGR of 7.55% during the years
2021-2028. The United States and Canada outline the market in this region.
Over the years, several drugs for hormone replacement therapy have been
approved, augmenting the growth of the reviewed market in the United States.
For instance, as per Symphony Health Solutions, the FDA-approved estrogen and
progestin drug products to treat vasomotor symptoms generated a significant
amount of revenue, further intensifying the market’s growth. Additionally, the
rise in the geriatric population is another leading factor that has resulted in
the rise of disorders, such as menopause and hypothyroidism. This increase is
likely to amplify the need for hormone therapy. Hence, all these above-stated
factors are expanding the scope and growth of the hormone replacement therapy
market.
Progestin is considered to prevent uterine cancer in women that have not
undergone hysterectomy, surgical removal of the uterus. Thus, the availability
of hormone replacement therapy is predicted to support the market’s growth over
the registered period. Additionally, it is estimated that every ten persons
above the age of 80 will live in senior homes in the upcoming years. Therefore,
the rise in the aging population is likely to boost the demand for hormone
therapy, thereby influencing the growth of the hormone replacement therapy
market across Canada.
COMPETITIVE OUTLOOK
The key companies in the hormone replacement therapy market consist of
Teva Pharmaceutical Industries Ltd, Noven Pharmaceuticals Inc, Abbott
Laboratories, Ipsen, ANI Pharmaceuticals, Dr Reddy’s Laboratories Ltd, and
Genentech Inc.
Get more insights into the North America Hormone Replacement Therapy
Market:
https://www.tritonmarketresearch.com/reports/north-america-hormone-replacement-therapy-market
SEGMENTATION
1. ABBOTT LABORATORIES
2. AMGEN
3. ANI PHARMACEUTICALS
4. BAYER AG
5. DR REDDY’S LABORATORIES LTD
6. ELI LILLY & COMPANY
7. GENENTECH INC
8. IPSEN
9. MERCK KGAA
10. NOVARTIS AG
11. NOVEN PHARMACEUTICALS INC
12. NOVO NORDISK A/S
13. PFIZER INC
14. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.
VIATRIS INC (MYLAN NV)
Comments
Post a Comment